Showing 771-780 of 868 results for "".
Acquired Dermal Macular Hyperpigmentation
https://practicaldermatology.com/topics/pigmentary-disorders/acquired-dermal-macular-hyperpigmentation/67257/Acquired dermal macular hyperpigmentation (ADMH) encompasses a group of chronic acquired pigmentary dermatoses characterized by the presence of dermal pigmentation.Moisturizers for Skin Diseases: New Insights
https://practicaldermatology.com/topics/atopic-dermatitis/moisturizers-for-skin-diseases-new-insights/22977/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20495/Addressing Antibiotic Resistance in Acne Regimens
https://practicaldermatology.com/topics/general-topics/addressing-antibiotic-resistance-in-acne-regimens/21248/As antibiotic resistance increasingly poses significant challenges, dermatologists should make necessary adjustments in the treatment of acne.“Natural” Remedies for Eczema: Evidence for the Alternative?
https://practicaldermatology.com/topics/general-topics/natural-remedies-for-eczema-evidence-for-the-alternative/22936/Limited data suggest the possibility that some natural agents may be particularly useful in the treatment of atopic dermatitis.Managing Acne and Rosacea in the Aesthetic Patient
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/managing-acne-and-rosacea-in-the-aesthetic-patient/23732/Sometimes patients seeking aesthetic interventions don’t even realize there is help for their inflamed skin.Cannabinoid Photo-Rejuvenation: A Clinico-Pathologic Study
https://practicaldermatology.com/topics/feature/cannabinoid-photo-rejuvenation-a-clinico-pathologic-study/29188/In this study, we sought to assess the effectiveness of a novel topical formulation containing CBD isolate, resveratrol, thyme extract, caffeine, and lecithin in reversing photodamage over a 90-day treatment period.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-4/23071/Icotrokinra and the Oral Therapy Revolution
https://practicaldermatology.com/topics/psoriasis/icotrokinra-and-the-oral-therapy-revolution/60986/Icotrokinra is the only commercially available therapy that selectively blocks the receptor of IL-23 rather than the IL-23 cytokine.The Future of Treatment and Research for Giant Congenital Melanocytic Nevi
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-future-of-treatment-and-research-for-giant-congenital-melanocytic-nevi/57252/Congenital melanocytic nevi (CMN) have long posed a clinical paradox: lesions that are often benign in behavior yet burdened by a measurable risk of melanoma and significant psychosocial impact. Present at birth or emerging in early infancy, CMN vary widely in size, distribution, and long-term impli